Mirbeg-25 (Mirabegron Extended Release Tablet) 25mg

Mirbeg-25 (Mirabegron Extended Release 25mg) is a prescription tablet used for overactive bladder management. It helps reduce frequent urination and urgency symptoms. Store at room temperature and keep out of reach of children. This medication is available in a 100-tablet pack.

Strength

25mg

Pack Size

100s

Storage

Ambient

Manufacturer / TM Owner

IPCA Laboratories LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mirbeg-25 (Mirabegron Extended Release 25mg) is commonly used to treat symptoms of overactive bladder such as frequent urination, urgency, and incontinence. It belongs to a class of medications that help relax the bladder muscles, making it easier to control urination. People often ask, what is mirbeg-25 used for, and the answer is managing bladder control issues in adults.

Side Effects

Mirbeg-25 may help reduce sudden urges to urinate and the number of times you need to go. Some users notice improved bladder control within a few weeks of starting the medication. Common effects include dry mouth or mild headache, which are usually temporary. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Keep Mirbeg-25 in a cool, dry place away from direct sunlight. Store at room temperature and ensure the bottle is tightly closed when not in use. Avoid exposing the tablets to moisture or extreme heat. Keep this medication out of reach of children and pets to prevent accidental ingestion.

Avoid Interactions

Mirbeg-25 may interact with other medications, including certain antidepressants, antifungals, and heart rhythm drugs. Avoid consuming alcohol while taking this medication, as it may increase side effects like dizziness. Always inform your doctor about all prescription and over-the-counter drugs you are using.

Frequently Asked Questions

Mirbeg-25 is used to treat symptoms of overactive bladder, such as frequent urination and urgency.

Store Mirbeg-25 at room temperature in a dry place, away from moisture and direct sunlight.

Consult a healthcare provider before combining Mirbeg-25 with other drugs to avoid potential interactions.

Common side effects may include dry mouth, headache, or mild dizziness.

Long-term use should be monitored by a healthcare professional to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.